James Shaffer, MD
Critical Care Medicine · Cookeville, TNNPI 1801859368
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $1,245, 4.2 times the $299 reported in 2019.
Across 38 payments — averaging $47.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- GSK$225
- AstraZeneca$223
- Intuitive Surgical$67
- Sanofi$33
- Insmed, Inc.$32
- plus $126 from 6 others
What the payments were for
- Travel & lodging$81445%
- Food & beverage$97754%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,116 |
| GSK | 12 | $225 |
| AstraZeneca | 2 | $223 |
| Intuitive Surgical | 1 | $67 |
| Sanofi | 2 | $33 |
| Insmed, Inc. | 2 | $32 |
| Portola Pharmaceuticals, LLC | 1 | $30 |
| Verona Pharma, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUMISITE$891
- TEZSPIRE$120
- TRELEGY ELLIPTA$108
- BREZTRI$103
How this compares
$1,823 in reported general payments places this provider in the 70th percentile of 141 critical care medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $55,283 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $9,299 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 16 | $7,248 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,249 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 118 | $3,444 |
| Azelastine Hcl | 25 | $706 |
| Doxycycline Hyclate | 63 | $466 |
| Prednisone | 101 | $360 |
| Azithromycin | 28 | $293 |
| Fluticasone Propionate | 23 | $187 |
| Doxycycline Monohydrate | 19 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $225 | $69,832107 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 141 critical care medicine providers in Tennessee.
Other critical care medicine in Cookeville
- Gordon BernardNashville$730K
- Todd RiceNashville$291K
- Jeffery NelsonMaryville$147K
- Jeremy GreenbergChattanooga$64K
- Anthony MattoxMemphis$33K
- Jamie DeneauNashville$33K
- Ann GageNashville$22K
- Nathan WildsMemphis$19K
- Lora Cooper-YoakumKnoxville$18K
- Lorraine WareNashville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.